Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director comp.
Appointed director
CC transcript
Asset disposition
Quarterly results
Appointed CFO
|
|
ImmunoGen, Inc. (IMGN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/04/2018 |
BW
| ImmunoGen Reports Recent Progress and First Quarter 2018 Operating Results |
| 04/20/2018 |
BW
| ImmunoGen Announces Conference Call to Discuss Its First Quarter 2018 Operating Results |
| 02/09/2018 |
BW
| ImmunoGen Reports Pipeline Progress and 2017 Operating Results |
| 01/26/2018 |
BW
| ImmunoGen Announces Conference Call to Discuss Its 2017 Operating Results |
| 01/02/2018 |
BW
| ImmunoGen Announces Webcast of Presentation and Q&A at the 36th Annual J.P. Morgan Healthcare Conference |
| 11/03/2017 |
BW
| ImmunoGen Reports Recent Progress and Third Quarter 2017 Operating Results |
| 10/20/2017 |
BW
| ImmunoGen Announces Conference Call to Discuss Its Third Quarter 2017 Financial Results |
| 07/28/2017 |
BW
| ImmunoGen Reports Recent Progress and Second Quarter 2017 Operating Results |
| 07/14/2017 |
BW
| ImmunoGen Announces Conference Call to Discuss Its Second Quarter 2017 Financial Results |
| 05/24/2017 |
BW
| ImmunoGen Announces Webcast of Presentation at the Jefferies Global Healthcare Conference |
| 05/05/2017 |
BW
| ImmunoGen Reports Recent Progress and First Quarter 2017 Operating Results |
| 04/21/2017 |
BW
| ImmunoGen Announces Conference Call to Discuss Its First Quarter 2017 Financial Results |
| 02/17/2017 |
BW
| ImmunoGen Reports Recent Progress and Operating Results for Six-Month Period and Quarter Ended December 31, 2016 |
| 02/02/2017 |
BW
| ImmunoGen Announces Webcasts of Presentations at Upcoming Investor Conferences |
| 06/05/2011 |
BW
| ImmunoGen, Inc. Announces Positive Clinical Data Presented on IMGN901 in the Treatment of Multiple Myeloma |
| 06/04/2011 |
BW
| ImmunoGen, Inc. Announces Presentation of Favorable SAR3419 Interim Clinical Data at ASCO |
| 06/01/2011 |
BW
| ImmunoGen, Inc. Announces Webcast of Presentation at Jefferies 2011 Global Healthcare Conference |
| 05/20/2011 |
BW
| ImmunoGen, Inc. Prices Public Offering of Common Stock |
| 05/03/2011 |
BW
| ImmunoGen, Inc. Announces Webcast of Presentation at Bank of America Merrill Lynch 2011 Health Care Conference |
| 04/21/2011 |
BW
| ImmunoGen, Inc. Announces Conference Call to Discuss its Third Quarter Fiscal Year 2011 Financial Results |
| 04/07/2011 |
BW
| T-DM1 Significantly Improved Progression-Free Survival in Randomized Phase II Trial |
| 04/04/2011 |
BW
| ImmunoGen, Inc. Announces First Data for its Novel Therapeutic for Ovarian Cancer and Other Carcinomas |
| 04/04/2011 |
BW
| ImmunoGen, Inc. Announces First Data for Its IMGN529 Product Candidate for Non-Hodgkin's Lymphoma |
| 03/30/2011 |
BW
| ImmunoGen, Inc. Announces Presentations at the 102nd Annual Meeting of the American Association for Cancer Research |
| 12/10/2010 |
BW
| ImmunoGen, Inc. Announces Clinical Data for T-DM1 Used in Combination with Pertuzumab for First-Line Treatment of HER2+ Metastatic Breast Cancer |
| 11/19/2010 |
BW
| ImmunoGen, Inc. Announces Presentation of Encouraging Clinical Data for IMGN388 at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics |
| 11/17/2010 |
BW
| ImmunoGen, Inc. Announces Clinical Data Presentations at the 52nd ASH Annual Meeting and Exposition |
| 11/10/2010 |
BW
| ImmunoGen, Inc. Announces Webcast of Presentation at Lazard Capital Markets 7th Annual Healthcare Conference |
| 11/02/2010 |
BW
| ImmunoGen, Inc. Announces Presentations at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics |
| 10/28/2010 |
BW
| ImmunoGen, Inc. Reports First Quarter Fiscal Year 2011 Financial Results |
| 10/19/2010 |
BW
| ImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor Conferences |
| 10/11/2010 |
BW
| ImmunoGen, Inc. Announces Presentation of Encouraging Clinical Data for Lorvotuzumab Mertansine at ESMO Annual Meeting |
| 10/11/2010 |
BW
| ImmunoGen, Inc. Announces Updated Guidance for 2011 Fiscal Year |
| 10/11/2010 |
BW
| ImmunoGen, Inc. Announces Conference Call at 8:30 am ET October 11, 2010 to Discuss New Collaboration and Updated Guidance for Fiscal Year 2011 |
|
|
|